Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.19.1
Income Taxes
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Income Taxes

12. Income Taxes

No provision for income taxes was recorded for the years ended December 31, 2018 and 2017. The Company has established a full valuation allowance against its deferred tax assets due to the uncertainty surrounding the realization of such assets. All losses to date have been incurred domestically.

The effective tax rate of the Company’s provision (benefit) for income taxes differs from the federal statutory rate as follows:

 

 

 

Year Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Federal statutory rate

 

 

21.0

%

 

 

34.0

%

 

 

34.0

%

State tax

 

 

-

 

 

 

-

 

 

 

-

 

Change in valuation allowance

 

 

(32.7

)

 

 

20.8

 

 

 

53.0

 

Tax credits

 

 

7.5

 

 

 

3.8

 

 

 

(21.6

)

Stock compensation

 

 

(0.5

)

 

 

-

 

 

 

-

 

Remeasurement of federal tax rate change

 

 

-

 

 

 

(63.4

)

 

 

-

 

Other

 

 

4.7

 

 

 

4.8

 

 

 

(65.4

)

Total

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

The components of the Company’s deferred tax assets consist of the following:

 

 

 

December 31

 

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

29,296

 

 

$

23,820

 

Research and development credits

 

 

15,680

 

 

 

11,244

 

Deferred revenue

 

 

3,027

 

 

 

3,004

 

Accruals and other

 

 

2,342

 

 

 

1,103

 

Fixed asset basis

 

 

363

 

 

 

-

 

Total deferred tax assets

 

 

50,708

 

 

 

39,171

 

Valuation allowance

 

 

(50,708

)

 

 

(39,135

)

Net deferred tax assets

 

 

-

 

 

 

36

 

Deferred tax liability

 

 

-

 

 

 

(36

)

Net deferred tax assets

 

$

-

 

 

$

-

 

 

Realization of the future tax benefits is dependent on the Company’s ability to generate sufficient taxable income within the carryforward period. Due to the Company’s history of operating losses and future sources of taxable income, the Company believes that the recognition of the deferred tax assets is currently not more likely than not to be realized and, accordingly, have provided a full valuation allowance against net deferred tax assets. For the year ended December 31, 2018, the net increase in the valuation allowance was $11.6 million, and for the year ended December 31, 2017, the net decrease in the valuation allowance was $4.0 million.

As of December 31, 2018, the Company had federal net operating loss carryforwards of $114.0 million and federal general business credits from research and development expenses totaling $10.9 million, as well as state net operating loss carryforwards of $73.4 million and state research and development credits of $9.5 million.

The federal net operating loss carryforwards will expire at various dates beginning in 2032, and the federal credits will expire at various dates beginning in 2023, if not utilized. The state net operating loss carryforwards will expire at various dates beginning in 2030, if not utilized. The state research and development tax credits can be carried forward indefinitely.

Under the Tax Reform Act, the amount of benefit from net operating loss carryforwards may be impaired or limited in certain circumstances. Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50%, as defined, over a three-year testing period. Such limitations may result in limitations upon the Company’s ability to utilize the losses in future periods. The Company has performed a Section 382 study for the period of June 16, 2003 through December 31, 2018, and concluded that it is more likely than not that the Company experienced an ownership change on April 9, 2007. This change does not limit the Company’s ability to use its existing net operating losses within the carryforward period provided by the Internal Revenue Code, subject to availability of taxable income. However, if there is subsequent event or further change in ownership, these losses may be subject to limitations, resulting in their expiration before they can be utilized.

The Company files U.S. federal and state tax returns with varying statutes of limitations. Due to net operating loss and credit carryforwards, all of the tax years since inception through the 2018 tax year remain subject to examination by the U.S. federal and some state authorities. The actual amount of any taxes due could vary significantly depending on the ultimate timing and nature of any settlement. The amount of unrecognized tax benefits, if recognized, that would affect the effective tax rate is $2.8 million, $2.3 million and $1.6 million as of December 31, 2018, 2017 and 2016, respectively. One or more of these unrecognized tax benefits could be subject to a valuation allowance if and when recognized in a future period, which could impact the timing of any related effective tax rate benefit. The Company believes that the amount by which the unrecognized tax benefits may increase or decrease within the next 12 months is not estimable.

The Company has elected to recognize, if incurred, interest and penalties related to liabilities for uncertain tax positions as a part of income tax expense. No such interest and penalties have been incurred to date.

The Company determines its uncertain tax positions based on a determination of whether and how much of a tax benefit taken by the Company in its tax filings is more likely than not to be sustained upon examination by the relevant income tax authorities.

A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:

 

 

 

December 31

 

 

 

2018

 

 

2017

 

 

2016

 

 

 

(in thousands)

 

 

 

 

 

Gross unrecognized tax benefit at January 1

 

$

2,305

 

 

$

1,635

 

 

$

1,205

 

Additions for tax positions taken in the current year

 

 

741

 

 

 

670

 

 

 

430

 

Reductions for tax positions of prior years

 

 

(251

)

 

 

-

 

 

 

-

 

Gross unrecognized tax benefit at December 31

 

$

2,795

 

 

$

2,305

 

 

$

1,635

 

 

Impact of The Tax Cuts and Jobs Act

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law. The Tax Act reduces the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%. The Tax Act also contains a number of provisions, many of which differ significantly from those contained in previous U.S. tax law. The Company accounts for changes in tax law in accordance with ASC 740 which requires companies to recognize the effect of such changes in the period of enactment. However, on December 22, 2017, the Securities Exchange Committee staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) which allowed companies to record provisional amounts during a measurement period that was similar to the measurement period used when accounting for business combinations. Accordingly, the Company adjusted its deferred taxes and related valuation allowances on a provisional basis to reflect the reduction in U.S. federal corporate tax rate from 35% to 21%, based on current understanding of the new law. The primary impact of the Tax Act resulted from the re-measurement of deferred tax assets and liabilities due to the change in the corporate tax rate, reducing the Company’s deferred tax assets by $12.3 million with a corresponding reduction in its valuation allowance, which had no effect on the Company’s effective tax rate.  As of December 31, 2018, the Company has completed its analysis of the income tax effects of the Tax Act and there was no material impact to the Company’s financial statements when the analysis was complete.